Sharps Stock (NASDAQ:STSS)

Ownership Financials Chart

Previous Close

$8.89

52W Range

$3.30 - $1.62K

50D Avg

$7.29

200D Avg

$153.38

Market Cap

$8.67M

Avg Vol (3M)

$1.21M

Beta

2.30

Div Yield

-

STSS Company Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

55

IPO Date

Apr 14, 2022

Website

STSS Performance

STSS Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-9.63M	$-10.13M	$-8.74M
Net Income	$-9.30M	$-9.84M	$779.88K
EBITDA	$-9.63M	$-8.98M	$-2.66M
Basic EPS	$-7.40	$-0.76	$0.10
Diluted EPS	$-7.40	$-0.76	$0.10

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

Ticker	Company
POAI	Predictive Oncology Inc.
HTCR	HeartCore Enterprises, Inc.
NXGL	NEXGEL, Inc.
PDEX	Pro-Dex, Inc.
SPRC	SciSparc Ltd.
ACON	Aclarion, Inc.
GCTK	GlucoTrack, Inc.
HSCS	HeartSciences Inc.